Pulmonary Tuberculosis Summary

Networked: 9033 relevant articles (243 outcomes, 910 trials/studies) for this Disease

Key Drugs and Agents for Pulmonary Tuberculosis

1. Isoniazid (Ftivazide) : 35 outcomes 120 studies in 1011 results : FDA 49 Generic
   
2. Rifampin (Rifampicin) : 24 outcomes 82 studies in 603 results : FDA 13 Generic
   
3. Streptomycin (Streptomycin Sulfate) : 14 outcomes 49 studies in 646 results : FDA 7
   
4. BCG Vaccine : 12 outcomes 4 studies in 32 results : FDA 1
   
5. Antigens : 8 outcomes 27 studies in 273 results : IBA
   
6. Pyrazinamide : 8 outcomes 27 studies in 247 results : FDA 3 Generic
   
7. butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB) : 8 outcomes 24 studies in 142 results : IBA
   
8. Ethambutol (Myambutol) : 8 outcomes 20 studies in 324 results : FDA 4 Generic
   
9. Tuberculin (PPD) : 7 outcomes 39 studies in 421 results : IBA
   
10. Anti-Bacterial Agents (Antibiotics) : 7 outcomes 11 studies in 181 results : IBA
    

Diseases Related to Pulmonary Tuberculosis

1. Tuberculosis (Tuberculoses)
2. Infection
3. Body Weight (Weight, Body)
4. Meningeal Tuberculosis (Tuberculous Meningitis)
5. Respiratory Insufficiency (Respiratory Failure)

Key Therapies for Pulmonary Tuberculosis

1. Drug Therapy (Chemotherapy) : 45 outcomes 146 studies in 1233 results
   
2. Retreatment : 3 outcomes 23 studies in 112 results
   
3. Immunotherapy : 3 outcomes 11 studies in 35 results
   
4. Pneumonectomy (Lung Volume Reduction) : 2 outcomes 6 studies in 131 results
   
5. Collapse Therapy : 2 outcomes 3 studies in 146 results